American Healthcare Capital is the exclusive representative of an innovative AI software platform that can efficiently coordinate patient referrals and follow-up care. The AI system has been in development for 7 years and is currently used daily at a major medical center to drastically reduce missed revenue from patient referrals that do not end up leading to appointments.
The technology eliminates the need for manually scheduling patient appointments and can even prompt patients ahead of time to prevent missed appointments. Patients can schedule their own appointments online, through an app, or by text message instead of time-consuming one-on-one phone calls with staff.
As a result, healthcare workers can focus on direct patient care while patients have an improved experience without dealing with complicated phone menus, hold times, and scheduling. Providers and hospitals can decrease missed referrals and boost revenue.
The AI software platform, protected by two owned US patents and a pending patent, is currently operating at a single medical center. It is now ready to expand across healthcare by leveraging its easy integration and scalability.
The company first wants to market to individual healthcare providers, then expand to healthcare institutions, payers, and IPAs. The plan is to strengthen the current organization by hiring experienced management and sales while outsourcing PR and attending healthcare events.
The company’s solution is the most advanced in the market and ahead of all current competitors.
The company founders are seeking a strategic partner to bring the technology to more hospitals and primary care physicians nationwide while continuing to develop the software platform. The company is open to any deal structure, including full or majority sale and equity investment, working toward mutually agreeable terms that may include future payouts. The asking price excludes cash and accounts receivable.
